Molecular techniques for the personalised management of patients with chronic myeloid leukaemia

Chronic myeloid leukemia (CML) is the paradigm for targeted cancer therapy. RT-qPCR is the gold standard for monitoring response to tyrosine kinase-inhibitor (TKI) therapy based on the reduction of blood or bone marrow BCR-ABL1. Some patients with CML and very low or undetectable levels of BCR-ABL1...

Descripción completa

Detalles Bibliográficos
Autores principales: Alikian, Mary, Gale, Robert Peter, Apperley, Jane F, Foroni, Letizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348117/
https://www.ncbi.nlm.nih.gov/pubmed/28331814
http://dx.doi.org/10.1016/j.bdq.2017.01.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348117/
https://www.ncbi.nlm.nih.gov/pubmed/28331814
http://dx.doi.org/10.1016/j.bdq.2017.01.001

Ejemplares similares